Periodic Reporting for period 3 - RESHAPE (Reshaping undesired Inflammation in challenged Tissue Homeostasis by Next-Generation regulatory T cell (Treg) Approaches – from Advanced Technology Developments to First-in-Human Trials)

It is generally accepted that the frequency of immunological diseases is increasing and represents a major public health burden with limited therapy options. Advanced therapeutic medicinal products (ATMP) offer a novel approach to treating highly prevalent diseases. Moreover...